Simon
Investment Committee
Simon Michel is the CEO of Ypsomed, the leading developer of self-injection systems for treatment of chronic disease. He also chairs the board of the DCB, a global center for diabetes technology innovation that transforms diagnosis and treatment and improves quality of life, and has held various other board, trustee and advisory roles including at Unitectra, sitem-insel, Forster Rohner, LEM Surgical and Swiss Medtech.